Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-09T01:31:41.021Z Has data issue: false hasContentIssue false

Effect of garlic (Allium sativum) powder tablets on serum lipids, blood pressure and arterial stiffness in normo-lipidaemic volunteers: a randomised, double-blind, placebo-controlled trial

Published online by Cambridge University Press:  09 March 2007

Beate Turner*
Affiliation:
Dansk Droge, Industrigrenen 10, DK-2635 Ishøj, Denmark
Christian Mølgaard
Affiliation:
Department of Human Nutrition and Centre for Advanced Food Studies, The Royal Veterinary and Agricultural University, Rolighedsvej 30, DK-1958 Frederiksberg C, Denmark
Peter Marckmann
Affiliation:
Medical Department, Roskilde Hospital, DK-4000 Roskilde, Denmark
*
*Corresponding author: Dr Beate Turner, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Recent studies have cast doubt on the proposed lipid-lowering and blood pressure-lowering effects of garlic. We tested the effect of dried garlic (Allium sativum) powder on blood lipids, blood pressure and arterial stiffness in a 12-week randomised, double-blind, placebo-controlled trial. Seventy-five healthy, normo-lipidaemic volunteers (men and women aged 40–60 years) were assigned to dried garlic powder tablets (10·8 mg alliin (3-(2-propenylsulfinyl)-l-alanine)/d, corresponding to about three garlic cloves) or placebo. Sixty-two subjects were eligible for the per-protocol analysis. The primary outcome measure was serum total cholesterol concentration. Secondary outcome measures were LDL-cholesterol, HDL-cholesterol and triacylglycerol concentrations, blood pressure and arterial stiffness (assessed by pulse wave velocity). No significant differences between the garlic and placebo groups were detected for any of the outcome measures. However, garlic powder was associated with a near-significant decrease (12 %) in triacylglycerol concentration (P=0·07). In conclusion, garlic powder tablets have no clinically relevant lipid-lowering and blood pressure-lowering effects in middle-aged, normo-lipidaemic individuals. The putative anti-atherosclerotic effect of garlic may be linked to risk markers other than blood lipids.

Type
Research Article
Copyright
Copyright © The Nutrition Society 2004

References

Adler, AJ & Holub, BJ (1997) Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men. Am J Clin Nutr 65, 445450.CrossRefGoogle ScholarPubMed
Andersen, LT, Jensen, H, Haraldsdóttir, J (1996) Typical weights of foods. Scand J Nutr 40, S129S152.Google Scholar
Auer, W, Eiber, A & Hertkorn, E et al. (1990) Hypertension and hyperlipidaemia: garlic helps in mild cases. Br J Clin Pract 44, Suppl, 36.Google Scholar
Berthold, HK, Sudhop, T & Von Bergmann, K (1998) Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial. J Am Med Assoc 279, 19001902.CrossRefGoogle ScholarPubMed
Breithaupt-Grögler, K, Ling, M, Boudoulas, H & Belz, GG (1997) Protective effect of chronic garlic intake on elastic properties of aorta in the elderly. Circulation 96, 26492655.CrossRefGoogle ScholarPubMed
Byrne, DJ, Neil, HAW, Vallance, DT & Winder, AF (1999) A pilot study of garlic consumption shows no significant effect on markers of oxidation or sub-fraction composition of low-density lipoprotein including lipoprotein(a) after allowance for non-compliance and the placebo effect. Clin Chim Acta 285, 2133.CrossRefGoogle ScholarPubMed
De Santos, AOS & Grunwald, J (1993) Effect of garlic powder tablets on blood lipids and blood pressure – a six month placebo controlled, double blind study. Br J Clin Res 4, 3744.Google Scholar
Friedewald, WT, Levy, RI & Fredrickson, DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499502.CrossRefGoogle ScholarPubMed
Gardner, CD, Chatterjee, LM & Carlson, JJ (2001) The effect of a garlic preparation on plasma lipid levels in moderately hypercholesterolemic adults. Atherosclerosis 154, 213220.CrossRefGoogle ScholarPubMed
Holzgartner, H, Schmidt, U & Kuhn, U (1992) Comparison of the efficacy and tolerance of a garlic preparation vs. bezafibrate. Arzneimittelforschung 42, 14731477.Google ScholarPubMed
Isaacsohn, JL, Moser, M, Stein, EA, Dudley, K, Davey, JA, Liskov, E & Black, HR (1998) Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med 158, 11891194.Google Scholar
Jain, AK, Vargas, R, Gotzkowsky, S & McMahon, FG (1993) Can garlic reduce levels of serum lipids? A controlled clinical study. Am J Med 94, 632635.CrossRefGoogle ScholarPubMed
Kiesewetter, H, Jung, F, Pindur, G, Jung, EM, Mrowietz, C & Wenzel, E (1991) Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors. Int J Clin Pharmacol Ther Toxicol 29, 151155.Google ScholarPubMed
Kannar, D, Wattanapenpaiboon, N, Savige, G.S & Wahlqvist, ML (2001) Hypocholesterolemic effect of an enteric-coated garlic supplement. J Am Coll Nutr 20, 225231.CrossRefGoogle ScholarPubMed
Koescielny, J, Klüsendorf, D, Latza, R, Schmitt, R, Radtke, H & Siegel, G (1999) The antiatherosclerotic effect of Allium sativum. Atherosclerosis 144, 237249.CrossRefGoogle Scholar
Lash, JP, Cardoso, LR, Mesler, PM, Walczak, DA & Pollak, R (1998) The effect of garlic on hypercholesterolemia in renal transplant patients. Transplant Proc 30, 189191.Google Scholar
Luley, C, Lehmann-Leo, W, Möller, B, Martin, T & Schwartzkopff, W (1986) Lack of efficacy of dried garlic in patients with hyperlipoproteinemia. Arzneimittelforschung 36, 766768.Google ScholarPubMed
McCrindle, BW, Helden, E & Conner, WT (1998) Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med 152, 10891094.Google Scholar
Mader, FH (1990) Treatment of hyperlipidaemia with garlic-powder tablets. Evidence from the German Association of General Practitioners' multicentric placebo-controlled double-blind study. Arzneimittelforschung 40, 11111116.Google ScholarPubMed
Martyn, CN, Barker, DJP, Jespersen, S, Greenwald, S, Osmond, C & Berry, C (1995) Growth in-utero, adult-blood pressure, and arterial stiffness. Br Heart J 73, 116121.CrossRefGoogle Scholar
Munday, JS, James, KA, Fray, LM, Kirkwood, SW & Thompson, KG (1999) Daily supplementation with aged garlic extract, but not raw garlic, protects low density lipoprotein against in vitro oxidation. Atherosclerosis 143, 399404.CrossRefGoogle Scholar
Neil, HAW, Silagy, CA, Lancaster, T, Hodgeman, J, Vos, K, Moore, JW, Jones, L, Cahill, J & Fowler, GH (1996) Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and a meta-anlysis. J R Coll Phys Lond 30, 329334.Google Scholar
Simons, LA, Balasubramaniam, S, von Konigsmark, M, Parfitt, A, Simons, J & Peters, W (1995) On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis 113, 219225.CrossRefGoogle ScholarPubMed
Stevinson, C, Pittler, MH & Ernst, E (2000) Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med 133, 420429.CrossRefGoogle ScholarPubMed
Superko, HR & Krauss, RM (2000) Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a). J Am Coll Cardiol 35, 321326.Google Scholar
Turner, B, Mølgaard, C & Marckmann, P (2004) Effect of dried garlic powder tablets on postprandial increase in pulse wave velocity after fatty meal: preliminary observations. Scand J Nutr (submitted).Google Scholar
Vorberg, G & Schneider, B (1990) Therapy with garlic: results of a placebo-controlled, double-blind study. Br J Clin Pract Suppl 69, 711.Google ScholarPubMed